[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366438-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366438-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","methylation-of-tumor-suppressor-genes-on-chromosome-9-diagnostic-insights-from-a-nasopharyngeal-carcinoma","Methylation of Tumor Suppressor Genes on Chromosome 9: Diagnostic Insights from a Nasopharyngeal Carcinoma","","This case-control study examines methylation patterns of tumor suppressor genes on chromosome 9 in nasopharyngeal carcinoma (NPC). Methylation of DAPK, p16INK4α, p15INK4α, and p14ARF was assessed in 70 NPC biopsy samples and 60 non-cancerous swab samples using DNA extraction, bisulfite conversion, and methylation-specific PCR. Promoter hypermethylation occurred in 52.86%–87.14% of samples, with significant risk elevation for NPC. A composite methylation index (MI ≥ 0.25) showed 100% sensitivity and 50% specificity, supporting early diagnostic screening.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/methylation-of-tumor-suppressor-genes-on-chromosome-9-diagnostic-insights-from-a-nasopharyngeal-carcinoma/366438/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/methylation-of-tumor-suppressor-genes-on-chromosome-9-diagnostic-insights-from-a-nasopharyngeal-carcinoma/366438.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which tumor suppressor genes on chromosome 9 are evaluated in this study?","Question",{"text":63,"@type":64},"The study evaluates DAPK, p16INK4α, p15INK4α, and p14ARF, both individually and as a combined methylation signal.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were methylation statuses measured for NPC and control samples?",{"text":68,"@type":64},"Genomic DNA extraction and bisulfite modification were performed, followed by methylation-specific PCR (MSP) to determine methylation status.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance does the methylation index (MI ≥ 0.25) show?",{"text":72,"@type":64},"MI ≥ 0.25 yielded 100% sensitivity and 50% specificity, indicating strong sensitivity for diagnosing NPC and potential usefulness for early screening.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366438,1790196721,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \nEditorial Process: Submission:01/19/2025 Acceptance:06/04/2025  \nMethylation of Tumor Suppressor Genes on Chromosome 9: DiagnosticInsightsfrom aNasopharyngealCarcinomainVietnam Hue Hong Thieu, Thuy Ai Huyen Le, Thuan Duc Lao*  \nAbstract  \nBackground: Methylation represents the second hit in tumor development. In nasopharyngeal carcinoma (NPC), multiple tumor suppressor genes located on chromosome 9 under methylation. Aims: This first case-control study aims to explore the methylation characteristics of DAPK, p16INK4α, p15INK4α, and p14ARF, individually and in combination, to evaluate their potential as promising biomarkers for nasopharyngeal carcinoma (NPC) . Materials and methods: A total of 70 NPC biopsy samples and 60 non-cancerous swab samples were enrolled into the current study. Genomic DNA extraction, bisulfite modification, and methylation-specific PCR (MSP) were used to analyze methylation status. Statistical analyses, including odds ratio (OR) calculations and methylation index (MI) evaluation, were conducted to determine the association between methylation and nasopharyngeal carcinoma (NPC) . Results: Promoter hypermethylation was observed in 75.71%, 78.57%, 52. 86%, and 87 . 14% of samples for DAPK, p16INK4α, p15INK4α, and p14ARF, respectively. A significant association between the methylation status of these candidate genes and nasopharyngeal carcinoma (NPC) was identified. The methylation of these genes significantly increased the risk of NPC compared to control samples (OR > 1). Based on the methylation index (MI), 100% of NPC samples showed methylation in at least one gene (MI ≥ 0.25). An MI ≥ 0.25 demonstrated a sensitivity of 100% and a specificity of 50%, highlighting its potential as a diagnostic marker. Conclusion: This study highlights the potential of DAPK, p16INK4α, p15INK4α, and p14ARF methylation as biomarkers for the diagnosis and early screening of nasopharyngeal carcinoma (NPC) in Vietnamese patients. The findings support the use of a composite methylation index as a sensitive biomarker for the early detection and screening of NPC.  \nKeywords: DAPK-INK4α -methylation-diagnosis-early screening-nasopharyngeal carcinoma  \nAsian Pac J Cancer Prev, 26 (6), 2239-2245  \nIntroduction  \nNasopharyngeal carcinoma (NPC) is a malignant tumor that originates from the epithelial cells of the nasopharynx and is notably characterized by its high geographical prevalence in East and Southeast Asia [1, 2]. According to the report of Globocan (2020), there were 133,354 newly diagnosed cases of NPC worldwide, with 80,008 reported deaths attributed to the disease [3] . Unfortunately, duetothe absence of obvious symptoms in the early stages, most cases of nasopharyngeal carcinoma (NPC) are diagnosed at advanced stages, significantly reducing the chances of survival for NPC patients. [4-6] . A key challenge is developing effective strategies for the early identification and diagnosis of nasopharyngeal carcinoma (NPC), aiming to improve treatment outcomesand overall survival rates. This highlights the urgent need for reliable and effective biomarkers to facilitate the detection and screening of NPC in its early stages.  \nPrecise etiological classification is crucial for a deeper understanding of the underlying causes of nasopharyngeal  \ncarcinoma (NPC) and for guiding the development of effective early diagnostic and screening methods [7, 8] . Recent efforts have highlighted the role of epigenetic alterations, particularly the methylation of tumor suppressor genes (TSGs), which silences their function and plays a critical role in the tumorigenesis of NPC [1, 2, 6-9]. These epigenetic changes hold significant potential as biomarkers for the early screening and detection of NPC.  \nExtensive research has highlighted that the inactivation of tumor suppressor genes (TSGs) through methylation typically occurs in specific regions of certain chromosomes [10-12] . Previous studies have proposed that the loss of ch","cbCaibjXCVSSSNnE","https://ap.wps.com/l/cbCaibjXCVSSSNnE","pdf",540789,"English","# Abstract\n# Introduction\n# Materials and methods\n## Genomic DNA extraction and bisulfite modification\n## Methylation-specific PCR (MSP)\n## Statistical analysis (OR and MI) \n# Results\n# Conclusion","[{\"question\":\"Which tumor suppressor genes on chromosome 9 are evaluated in this study?\",\"answer\":\"The study evaluates DAPK, p16INK4α, p15INK4α, and p14ARF, both individually and as a combined methylation signal.\"},{\"question\":\"How were methylation statuses measured for NPC and control samples?\",\"answer\":\"Genomic DNA extraction and bisulfite modification were performed, followed by methylation-specific PCR (MSP) to determine methylation status.\"},{\"question\":\"What diagnostic performance does the methylation index (MI ≥ 0.25) show?\",\"answer\":\"MI ≥ 0.25 yielded 100% sensitivity and 50% specificity, indicating strong sensitivity for diagnosing NPC and potential usefulness for early screening.\"}]","Methylation of Tumor Suppressor Genes on Chromosome 9: Diagnostic Insights from a Nasopharyngeal Carcinoma | PDF",1790165570,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17e33cd900d80734952dfce0d450a046.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f2f3c9de3671fcc3a5fa9c7c6ad5ba6.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca04ac6e6e8bf402379b179d54101198.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07d17f4b26bd5627a441c7c583140b05.webp",980,1385]